awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
Graphs
1
Q47104482-472F308E-6CE8-45A7-9572-E7F3C65BA4D5
Q47104482-472F308E-6CE8-45A7-9572-E7F3C65BA4D5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47104482-472F308E-6CE8-45A7-9572-E7F3C65BA4D5
Guideline development for the management of gout: role of combination therapy with a focus on lesinurad.
P2860
Q47104482-472F308E-6CE8-45A7-9572-E7F3C65BA4D5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47104482-472F308E-6CE8-45A7-9572-E7F3C65BA4D5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
98ad202157aac44ae8f186b175545df04217f78c
P2860
A randomised controlled trial on the efficacy and tolerability with dose escalation of allopurinol 300-600 mg/day versus benzbromarone 100-200 mg/day in patients with gout.